共 50 条
- [4] Clinical Characteristics of Registry Participants with Psoriatic Arthritis Initiating Guselkumab: An Analysis from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry [J]. Drugs - Real World Outcomes, 2022, 9 : 617 - 628
- [7] Effectiveness of Tofacitinib in Patients Initiating Therapy for Psoriatic Arthritis: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry [J]. Rheumatology and Therapy, 2024, 11 : 313 - 329